SureTrader
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

r- the inertness of the mineral oil

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
HDGabor Member Profile
 
Followed By 44
Posts 5,521
Boards Moderated 1
Alias Born 10/07/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2018 5:02:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 5:27:59 PM
Amarin Prices Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/30/2018 8:58:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/29/2018 4:08:42 PM
Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/29/2018 4:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2018 6:01:14 PM
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events GlobeNewswire Inc. - 1/23/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/17/2018 5:59:57 PM
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China GlobeNewswire Inc. - 1/17/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 6:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 6:01:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2018 4:57:25 PM
Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook GlobeNewswire Inc. - 1/4/2018 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:34:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:33:51 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 12/22/2017 4:13:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/21/2017 4:04:15 PM
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018 GlobeNewswire Inc. - 12/19/2017 6:00:00 AM
Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco GlobeNewswire Inc. - 12/18/2017 4:30:00 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 12/4/2017 4:48:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2017 9:04:12 AM
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular ... GlobeNewswire Inc. - 11/14/2017 4:30:00 PM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Pat... GlobeNewswire Inc. - 11/13/2017 4:30:00 PM
Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical ... GlobeNewswire Inc. - 11/13/2017 6:00:00 AM
Amarin to Present at the Jefferies London Healthcare Conference GlobeNewswire Inc. - 11/7/2017 6:00:00 AM
HDGabor   Friday, 10/06/17 09:38:59 AM
Re: rosemountbomber post# 115623
Post # of 122767 
r-
Quote:
the inertness of the mineral oil placebo ... If that was a concern

The FDA tried to explain the changes observed in the mineral oil group, since the magnitude of the changes in several lipid and lipoprotein parameters, as well as biomarkers of inflammation, between baseline and Week 12 in the placebo group wre rather atypical for lipid-lowering trials. However they did not conclude anything
Quote:
These results suggest the changes in ANCHOR are atypical, but the etiology of this remains unclear

and did not suggest any change for R-IT.

Furthermore, R-IT is about clinical outcome (as PE and SEs) lipid values are TEs only (meanwhile ANCHOR was about lipids).

Best,
G


#NEWMIAMI

Disclosure:
I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Do Your Job
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist